CompletedPhase 1NCT01521832
Escalating Dose Study in Healthy Volunteers With SEN0014196
Studying Huntington's Disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Siena Biotech S.p.A.
- Principal Investigator
- Joseph A Chiesa, MDCovance
- Intervention
- SEN0014196(drug)
- Enrollment
- 88 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2009 – 2010
Study locations (1)
- Covance Clinical Research Unit, Leeds, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01521832 on ClinicalTrials.govOther trials for Huntington's Disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07246941A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's DiseaseHoffmann-La Roche
- RECRUITINGNANCT06807892Comparison of Two Cognitive-Motor Rehabilitation Approaches Via Exergames: a Study of Cognitive, Motor and Behavioral Functions in Huntington's Disease PatientsUniversity Hospital, Angers
- RECRUITINGNANCT07299682Facilitating Effective Eating With DoddleBags: A Single-Arm Acceptability Study Of DoddleBags to Assess Impact on Self Feeding Behaviours in a Huntington's Disease PopulationUniversity of Hull
- RECRUITINGPHASE1NCT06585449A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's DiseaseAlnylam Pharmaceuticals
- ACTIVE NOT RECRUITINGNCT07503743Biology-Driven Cognitive Profiling in Huntington's DiseaseFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04120493Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's DiseaseUniQure Biopharma B.V.
- RECRUITINGNCT02855476HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's DiseaseUniversity College, London
- RECRUITINGNCT01574053Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease CohortCHDI Foundation, Inc.